Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2.

Yang X, Wada T, Imadome K, Nishida N, Mukai T, Fujiwara M, Kawashima H, Kato F, Fujiwara S, Yachie A, Zhao X, Miyawaki T, Kanegane H.

Herpesviridae. 2012 Feb 10;3(1):1. doi: 10.1186/2042-4280-3-1.

2.

Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.

Wada T, Kanegane H, Ohta K, Katoh F, Imamura T, Nakazawa Y, Miyashita R, Hara J, Hamamoto K, Yang X, Filipovich AH, Marsh RA, Yachie A.

Cytokine. 2014 Jan;65(1):74-8. doi: 10.1016/j.cyto.2013.09.007. Epub 2013 Sep 29.

PMID:
24084330
3.

Lymphoproliferative Disease, X-Linked.

Zhang K, Wakefield E, Marsh R.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2004 Feb 27 [updated 2016 Jun 30].

4.

SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.

Yang X, Miyawaki T, Kanegane H.

Pediatr Int. 2012 Aug;54(4):447-54. doi: 10.1111/j.1442-200X.2012.03683.x. Review.

PMID:
22672194
5.

Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.

Chuang HC, Lay JD, Hsieh WC, Wang HC, Chang Y, Chuang SE, Su IJ.

Blood. 2005 Nov 1;106(9):3090-6. Epub 2005 Jul 7.

6.

Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease.

Sankararaman S, Riel-Romero RM, Jeroudi M, Gonzalez-Toledo E.

J Neurosci Rural Pract. 2014 Apr;5(2):171-4. doi: 10.4103/0976-3147.131669.

7.

Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.

Jin YY, Zhou W, Tian ZQ, Chen TX.

Hum Immunol. 2016 Aug;77(8):658-666. doi: 10.1016/j.humimm.2016.06.005. Epub 2016 Jun 8. Review.

PMID:
27288720
8.

Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).

Pachlopnik Schmid J, Canioni D, Moshous D, Touzot F, Mahlaoui N, Hauck F, Kanegane H, Lopez-Granados E, Mejstrikova E, Pellier I, Galicier L, Galambrun C, Barlogis V, Bordigoni P, Fourmaintraux A, Hamidou M, Dabadie A, Le Deist F, Haerynck F, Ouachée-Chardin M, Rohrlich P, Stephan JL, Lenoir C, Rigaud S, Lambert N, Milili M, Schiff C, Chapel H, Picard C, de Saint Basile G, Blanche S, Fischer A, Latour S.

Blood. 2011 Feb 3;117(5):1522-9. doi: 10.1182/blood-2010-07-298372. Epub 2010 Nov 30.

9.

Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.

Zhao M, Kanegane H, Kobayashi C, Nakazawa Y, Ishii E, Kasai M, Terui K, Gocho Y, Imai K, Kiyasu J, Nonoyama S, Miyawaki T.

Cytometry B Clin Cytom. 2011 Jan;80(1):8-13. doi: 10.1002/cyto.b.20552.

10.

HHV-8-related hemophagocytic lymphohistiocytosis in a boy with XLP phenotype.

Pasic S, Cupic M, Lazarevic I.

J Pediatr Hematol Oncol. 2012 Aug;34(6):467-71. doi: 10.1097/MPH.0b013e3182375372.

PMID:
22258354
11.

Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.

Marsh RA, Bleesing JJ, Filipovich AH.

J Immunol Methods. 2010 Oct 31;362(1-2):1-9. doi: 10.1016/j.jim.2010.08.010. Epub 2010 Sep 9.

12.

Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.

Tabata Y, Villanueva J, Lee SM, Zhang K, Kanegane H, Miyawaki T, Sumegi J, Filipovich AH.

Blood. 2005 Apr 15;105(8):3066-71. Epub 2005 Jan 4.

13.

Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.

Sun J, Ying W, Liu D, Hui X, Yu Y, Wang J, Wang X.

Scand J Immunol. 2013 Nov;78(5):463-7. doi: 10.1111/sji.12103.

14.

X-linked lymphoproliferative disease in an adult.

Hoshino T, Kanegane H, Doki N, Irisawa H, Sakura T, Nojima Y, Miyawaki S, Miyawaki T.

Int J Hematol. 2005 Jul;82(1):55-8.

PMID:
16105760
15.

Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses.

Miyawaki T.

Iran J Allergy Asthma Immunol. 2004 Jun;3(2):51-7.

16.

Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.

Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S.

Blood. 2001 Sep 15;98(6):1882-8.

17.
18.

Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.

Shinozaki K, Kanegane H, Matsukura H, Sumazaki R, Tsuchida M, Makita M, Kimoto Y, Kanai R, Tsumura K, Kondoh T, Moriuchi H, Miyawaki T.

Int Immunol. 2002 Oct;14(10):1215-23.

PMID:
12356686
19.

Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.

Toga A, Wada T, Sakakibara Y, Mase S, Araki R, Tone Y, Toma T, Kurokawa T, Yanagisawa R, Tamura K, Nishida N, Taneichi H, Kanegane H, Yachie A.

J Infect Dis. 2010 Jun 15;201(12):1923-32. doi: 10.1086/652752.

PMID:
20443735
20.

XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.

Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, Bleesing JJ, Zhang K, Filipovich AH.

Blood. 2010 Aug 19;116(7):1079-82. doi: 10.1182/blood-2010-01-256099. Epub 2010 May 20.

Supplemental Content

Support Center